These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7739347)

  • 1. Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine.
    Niwa M; al-Essa LY; Ohta S; Kohno K; Nozaki M; Tsurumi K; Iwamura T; Kataoka T
    Life Sci; 1995; 56(21):PL395-400. PubMed ID: 7739347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroetorphine is a mu-receptor-selective ligand.
    Wang DX; Lu XQ; Qin BY
    J Pharm Pharmacol; 1995 Aug; 47(8):669-73. PubMed ID: 8583370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitussive effect of dihydroetorphine in mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Binding of [3H] dihydroetorphine to opioid receptors in rat brain membrane].
    Wang DX; Qin BY
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):281-3. PubMed ID: 9812759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors.
    Katsumata S; Minami M; Nakagawa T; Iwamura T; Satoh M
    Eur J Pharmacol; 1995 Nov; 291(3):367-73. PubMed ID: 8719422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellum.
    Polastron J; Boyer MJ; Quertermont Y; Thouvenot JP; Meunier JC; Jauzac P
    J Neurochem; 1990 Feb; 54(2):562-70. PubMed ID: 2153754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
    Kamei J; Suzuki T; Nagase H
    Neurosci Lett; 1996 Sep; 215(2):87-90. PubMed ID: 8888002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
    Porthé G; Francés B; Verrier B; Cros J; Meunier JC
    Life Sci; 1988; 43(6):559-67. PubMed ID: 2841553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects.
    Ohmori S; Morimoto Y
    CNS Drug Rev; 2002; 8(4):391-404. PubMed ID: 12481194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
    Attali B; Saya D; Vogel Z
    J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor.
    Burd AL; El-Kouhen R; Erickson LJ; Loh HH; Law PY
    J Biol Chem; 1998 Dec; 273(51):34488-95. PubMed ID: 9852117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen.
    Noble F; Cox BM
    J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of morphine, etorphine and enkephalins with dopamine-stimulated adenylate cyclase of monkey amygdala.
    Walczak SA; Wilkening D; Makman MH
    Brain Res; 1979 Jan; 160(1):105-16. PubMed ID: 214205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of opioid receptor agonists on cAMP second messenger system.
    Liu JG; Gong ZH; Qin BY
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):452-6. PubMed ID: 10678096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
    Bot G; Blake AD; Li S; Reisine T
    Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of opioid and muscarinic receptors stimulates basal adenylyl cyclase but inhibits Ca2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb.
    Olianas MC; Onali P
    J Neurochem; 1994 Jul; 63(1):161-8. PubMed ID: 8207425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.